Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design

SIMPLE SUMMARY: Therapeutic cancer vaccines have failed to demonstrate clinical improvements in phase III clinical trials over the past two decades. This has led to a rather discouraging view regarding their role in the field of cancer immunotherapy. Herein, we critically examine important issues fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Baxevanis, Constantin N., Fortis, Sotirios P., Ardavanis, Alexandros, Perez, Sonia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600460/
https://www.ncbi.nlm.nih.gov/pubmed/33050520
http://dx.doi.org/10.3390/cancers12102908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600460/
https://www.ncbi.nlm.nih.gov/pubmed/33050520
http://dx.doi.org/10.3390/cancers12102908

Ejemplares similares